Russell Frank Company’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Russell Frank Company’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-597	Closed	-$40K	–	3090
2015 Q3	$40K	Sell	597 -16,981	-97%	-$1.39M	﹤0.01%	2921
2015 Q2	$1.71M	Sell	17,578 -1,493	-8%	-$142K	﹤0.01%	2059
2015 Q1	$1.78M	Sell	19,071 -9,921	-34%	-$844K	﹤0.01%	1839
2014 Q4	$2.53M	Buy	28,992 +4,001	+16%	+$291K	﹤0.01%	1646
2014 Q3	$1.73M	Buy	24,991 +10,206	+69%	+$545K	﹤0.01%	1813
2014 Q2	$688K	Buy	+14,785	New	+$751K	﹤0.01%	2215
2013 Q4	–	Sell	-62	Closed	-$2K	–	3261
2013 Q3	$2K	Buy	62 +49	+377%	+$1.71K	﹤0.01%	3374
2013 Q2	$1K	Buy	+13	New	+$570	﹤0.01%	3301

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Russell Frank Company's MACK Position: Q4 2015 in Review

Russell Frank Company sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2015, closing a stake of 597 shares — an estimated $40K sold.

Russell Frank Company first reported a position in MACK in Q2 2013 and held it in 8 quarters. The position peaked at $2.53M in Q4 2014. 139 funds tracked by Wall St. Rank hold MACK as of Q4 2015.

Russell Frank Company reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
Russell Frank Company sold 597 Merrimack Pharmaceuticals, Inc. shares in Q4 2015, an estimated $40K.
Russell Frank Company first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 8 quarters.
Russell Frank Company's Merrimack Pharmaceuticals, Inc. position peaked at $2.53M in Q4 2014.
139 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2015.

Based on Russell Frank Company's 13F filing for Q4 2015, filed 27 Jan 2016.